Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

701 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Increased risk of restenosis after placement of gold-coated stents: results of a randomized trial comparing gold-coated with uncoated steel stents in patients with coronary artery disease.
Kastrati A, Schömig A, Dirschinger J, Mehilli J, von Welser N, Pache J, Schühlen H, Schilling T, Schmitt C, Neumann FJ. Kastrati A, et al. Among authors: schomig a. Circulation. 2000 May 30;101(21):2478-83. doi: 10.1161/01.cir.101.21.2478. Circulation. 2000. PMID: 10831521 Clinical Trial.
Coronary stent placement in patients with acute myocardial infarction: comparison of clinical and angiographic outcome after randomization to antiplatelet or anticoagulant therapy.
Schömig A, Neumann FJ, Walter H, Schühlen H, Hadamitzky M, Zitzmann-Roth EM, Dirschinger J, Hausleiter J, Blasini R, Schmitt C, Alt E, Kastrati A. Schömig A, et al. J Am Coll Cardiol. 1997 Jan;29(1):28-34. doi: 10.1016/s0735-1097(96)00450-0. J Am Coll Cardiol. 1997. PMID: 8996291 Free article. Clinical Trial.
Major benefit from antiplatelet therapy for patients at high risk for adverse cardiac events after coronary Palmaz-Schatz stent placement: analysis of a prospective risk stratification protocol in the Intracoronary Stenting and Antithrombotic Regimen (ISAR) trial.
Schühlen H, Hadamitzky M, Walter H, Ulm K, Schömig A. Schühlen H, et al. Among authors: schomig a. Circulation. 1997 Apr 15;95(8):2015-21. doi: 10.1161/01.cir.95.8.2015. Circulation. 1997. PMID: 9133509 Clinical Trial.
Restenosis after coronary stent placement and randomization to a 4-week combined antiplatelet or anticoagulant therapy: six-month angiographic follow-up of the Intracoronary Stenting and Antithrombotic Regimen (ISAR) Trial.
Kastrati A, Schühlen H, Hausleiter J, Walter H, Zitzmann-Roth E, Hadamitzky M, Elezi S, Ulm K, Dirschinger J, Neumann FJ, Schömig A. Kastrati A, et al. Among authors: schomig a. Circulation. 1997 Jul 15;96(2):462-7. Circulation. 1997. PMID: 9244213 Clinical Trial.
Predictive factors of restenosis after coronary stent placement.
Kastrati A, Schömig A, Elezi S, Schühlen H, Dirschinger J, Hadamitzky M, Wehinger A, Hausleiter J, Walter H, Neumann FJ. Kastrati A, et al. Among authors: schomig a. J Am Coll Cardiol. 1997 Nov 15;30(6):1428-36. doi: 10.1016/s0735-1097(97)00334-3. J Am Coll Cardiol. 1997. PMID: 9362398 Free article.
701 results